Diagnostic Accuracy of Fine Needle Aspiration in Patients With Salivary Gland Tumors.
1 other identifier
observational
128
1 country
1
Brief Summary
Tumors of the salivary glands occupy 0.5-1.2% of cases of head and neck tumors. They are primarily a surgical disease, as their treatment is basically the surgical excision. In this direction and in the context of the differential preoperative diagnosis, in addition to the imaging methods, the fine needle biopsy (FNA) was used, with which cell material is aspirated from the tumor and studied under the microscope. Although an increasing number of papers have been published in the international scientific literature over the last 5 years on the diagnostic accuracy of FNA in salivary glands, many of them are unable to quantify and omit to refer information that could affect the estimated diagnostic accuracy. Such information is for instance the clinical experience of the doctor who performs the FNA and of the one who assess the smear. The aim of this retrospective study is to evaluate the diagnostic accuracy of fine needle biopsy in adult patients with salivary gland tumor that underwent a surgical excision in two Oral and Maxillofacial Departments in Northern Greece. The present retrospective study was carried out from 2/2021 to 4/2022 by collecting data from the files of patients who underwent surgery at the Oral and Maxillofacial Clinic of the Theageneio Cancer Hospital of Thessaloniki 1996-2022 and the General Hospital of Thessaloniki G. Papanikolaou 2015-2022. The study was conducted according to the STARD 2015 protocol. FNA contributed significantly to the differential preoperative process in salivary gland diseases. The differential diagnosis of a lesion in benign / malignant preoperatively, with the use of FNA, enables the surgeon for a more beneficial to the patient and oncologically safer planning of the surgery. It is considered important the high sensitivity provided by the examination, as it helps to exclude with sufficient safety the possible malignancy of the tumor located in the salivary gland of the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2022
CompletedFirst Submitted
Initial submission to the registry
August 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedSeptember 13, 2023
August 1, 2022
1.2 years
August 19, 2022
September 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of Fine Needle Aspiration in salivary tumors
The result FNA of salivary tumor was compared to (verified) Histologic result after tumor resection. Then Diagnostic accuracy of FNA was estimated.
Every patient underwent FNA in a time frame from 1 day to 1 month before the surgical resection of the tumor. Then, under general anesthesia the tumor was surgicaly resected and was immediately examined to the Histology Laboratory of the Hospital.
Study Arms (1)
patients with salivary gland tumors
patients with salivary gland tumors
Interventions
Fine Needle Aspiration of a salivary gland tumor
Histologic examination of resected salivary tumor
Eligibility Criteria
Adult patients with salivary tumors that examined in outpatient Oral and Maxillofacial Surgery Clinic of Anti-Cancer Hospital of Thessaloniki "Theageneio" and General Hospital of Thessaloniki "G. Papanikolaou".
You may qualify if:
- Adult patients \>=18 years
- salivary tumor suspected
- FNA result available
- Salivary tumor surgically resected
- Histologic result available
You may not qualify if:
- Patients under 18 years old
- FNA result or Histologic result not available
- No tumor resection
- Other neck tumors (not salivary tumor)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aristotle University
Thessaloniki, 54124, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Theodoros V. Grivas, Medical
Aristotle University Thessaloniki
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2022
First Posted
September 13, 2023
Study Start
February 22, 2021
Primary Completion
May 15, 2022
Study Completion
June 6, 2022
Last Updated
September 13, 2023
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Immediatelly available and for 6 months
- Access Criteria
- The excel database with the menioned individual participant data (IPD) can be available only for academical reason after email verification
SN,Sex,Clinic of Origin,Date of Birth,Age, Final Result of FNA (as included in Excel database),Histological result (as included in Excel database) are available to all researchers.